Key facts
- This page summarizes Daniel Faga's Form 4/A - Amendment filing for ANAPTYSBIO, INC (ANAB).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 23 Apr 2026, 18:07.
Daniel Faga - 20 Apr 2026 Form 4/A - Amendment Insider Report for ANAPTYSBIO, INC (ANAB)
- Reporting relationship
- President, CEO, Director
- Issuer ticker
- ANAB
- Reported as of
- 20 Apr 2026
- Net transaction value
- $0
- SEC form
- 4/A - Amendment
- Accepted by SEC
- 23 Apr 2026, 18:07:34 UTC
- Original report date
- 22 Apr 2026
- Prior SEC filing
- 01 Apr 2026
- Next SEC filing
- 14 May 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Dan Faga
Source evidence
Original filing metadata and source links for verification.
6 source fields
Reporting owner
1 detail
Key filing fact
Daniel Faga filed Form 4/A - Amendment for ANAPTYSBIO, INC (ANAB) on 23 Apr 2026.
Change
- Previous filing in this sequence was filed on 01 Apr 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.
Reporting Owners (1)
CIK 0001673528
Primary reporting owner
Faga Daniel
- Relationship
- President, CEO, Director
- Address
- C/O ANAPTYSBIO, INC., 10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO
- Signature
- /s/ Dan Faga
- Signature date
- 23 Apr 2026
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ANAB
transaction
Derivative
Employee Stock Option (right to buy)
Disposed to Issuer
- Transaction value
- Shares
- -11,000
- Change %
- -50%
- Price
- $0.000000*
- Shares after
- 11,000
- Date
- 20 Apr 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 11,000
- Exercise price
- $31.12
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The stock option is fully vested and exercisable.
SEC remarks
This amendment to Form 4, filed on April 23, 2026, updates the number of stock options to 11,000 shares of the Issuer's common stock.